Clear Street Markets LLC Takeda Pharmaceutical CO LTD Call Options Transaction History

Clear Street Markets LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 14, 2021	SELL	$16.71 - $19.9 $34,105 - $40,615	-2,041 Reduced 85.36%	350 $639,000
Q4 2020 Feb 25, 2021	SELL	$15.39 - $18.97 $41,399 - $51,029	-2,690 Reduced 52.94%	2,391 $43,000
Q3 2020 Oct 19, 2020	SELL	$17.1 - $19.19 $820 - $921	-48 Reduced 0.94%	5,081 $9.07 Million
Q2 2020 Aug 06, 2020	SELL	$14.59 - $19.5 $1,940 - $2,593	-133 Reduced 2.53%	5,129 $9.2 Million
Q1 2020 Apr 28, 2020	BUY	$13.02 - $20.31 $78 - $121	6 Added 0.11%	5,262 $7.99 Million
Q3 2019 Oct 18, 2019	SELL	$16.15 - $17.99 $12,823 - $14,284	-794 Reduced 13.12%	5,256 $9.04 Million
Q2 2019 Jul 16, 2019	BUY	$16.58 - $20.49 $100,308 - $123,964	6,050 New	6,050 $10.7 Million

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.